Dr. Howard Smith Oncall

  Vidcast:  https://youtu.be/4jmVx24TLiA   A full course of the Pfizer mRNA CoVid vaccine reduces that chance that an adolescent will develop the multi system inflammatory syndrome known as MIS-C by 91%.  A collaborative group of pediatric infectious disease specialists at 24 of our nation’s preeminent children’s hospitals and pediatric departments studied a total of 283 patients with a median age of 14.5 years during the Delta variant predominant period July through December of 2021.     Ninety-five percent of the adolescents who became infected with CoVid and developed symptoms of MIS-C were unvaccinated.  No CoVid-infected child who received the 2 doses of the Pfizer vaccine required mechanical ventilation or cardiovascular life support which 39% of the unvaccinated did.   MIS-C is a devastating illness that is largely preventable with CoVid vaccination and appropriate boosting.  Since only 52.3% of eligible teens 12 through 17 years had received the mRNA vaccine as of mid-December and a significantly lowe